K. Sasaki et al., Effects of bilobalide on gamma-aminobutyric acid levels and glutamic acid decarboxylase in mouse brain, EUR J PHARM, 367(2-3), 1999, pp. 165-173
We have previously demonstrated that bilobalide, a constituent of the Ginkg
o biloba extract, possesses anticonvulsant activity, and suggested that the
mechanism of its anticonvulsant action involves modulation of gamma-aminob
utyric acid (GABA)-related neuronal transmission. This study examined the e
ffects of bilobalide on the level of GABA and glutamate, the activity and t
he amount of glutamic acid decarboxylase (EC 4.1.1.15), and the function of
GABA(A) receptors in the hippocampus, cerebral cortex and striatum of the
mouse. GABA levels, glutamic acid decarboxylase activity, and the protein a
mount of 67 kDa glutamic acid decarboxylase in the hippocampus of mice trea
ted with bilobalide (30 mg/kg, p.o., once a day for 4 days) were significan
tly higher than those in controls. However, there were no significant diffe
rences in glutamate levels or, the number and the dissociation constants of
GABA(A) receptors in the hippocampus between control and bilobalide-treate
d mice. These results suggest that the anticonvulsant effect of bilobalide
is due to elevation of GABA levels, possibly through potentiation of glutam
ic acid decarboxylase activity and enhancement of the protein amount of 67
kDa glutamic acid decarboxylase by bilobalide. (C) 1999 Elsevier Science B.
V. All rights reserved.